CoChat

A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome

Open access

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Steroid-resistant nephrotic syndrome (SRNS) is the second most frequent cause of ESRD in the first two decades of life. Effective treatment is lacking. First insights into disease mechanisms came from identification of single-gene causes of SRNS. However, the frequency of single-gene causation and its age distribution in large cohorts are unknown. We performed exon sequencing of NPHS2 and WT1 for 1783 unrelated, international families with SRNS. We then examined all patients by microfluidic multiplex PCR and next-generation sequencing for all 27 genes known to cause SRNS if mutated. We detected a single-gene cause in 29.5% (526 of 1783) of families with SRNS that manifested before 25 years of age. The fraction of families in whom a single-gene cause was identified inversely correlated with age of onset. Within clinically relevant age groups, the fraction of families with detection of the single-gene cause was as follows: onset in the first 3 months of life (69.4%), between 4 and 12 months old (49.7%), between 1 and 6 years old (25.3%), between 7 and 12 years old (17.8%), and between 13 and 18 years old (10.8%). For PLCE1, specific mutations correlated with age of onset. Notably, 1% of individuals carried mutations in genes that function within the coenzyme Q10 biosynthesis pathway, suggesting that SRNS may be treatable in these individuals. Our study results should facilitate molecular genetic diagnostics of SRNS, etiologic classification for therapeutic studies, generation of genotype-phenotype correlations, and the identification of individuals in whom a targeted treatment for SRNS may be available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.2014050489

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Geographic distribution of the study cohort of 1783 families with SRNS. The number of affected families in the respective countries or cities is represented by the surface area (red) of a circle. Data from countries not represented on the map are shown in the blue box. Insert shows higher resolution of the New York Metropolitan area.
Figure 1 Geographic distribution of the study cohort of 1783 families with SRNS. The number of affected families in the respective countries or cities is represented by the surface area (red) of a circle. Data from countries not represented on the map are shown in the blue box. Insert shows higher resolution of the New York Metropolitan area.CC-BY-NC-ND · From the PDF
Image 2
CC-BY-NC-ND · From the PDF
Figure 3 Detection of the causative mutation in 502 families in an international cohort of 1617 families with SRNS in 21 SRNS-causing genes in relation to age of onset of proteinuria in clinically relevant age groups. The displayed 502 families represent the number of families with detected causative mutation and available data for age of onset of proteinuria , 26 years. (A) Percentage of families with causative mutation detected per gene per age group. Histograms indicate fraction (in percentage) of families with causative gene detected in n families per families examined (on top of histograms) per age group. (B) Percentages shown in A are represented by separate bars to highlight distribution across age groups as further delineated in C. Note that mutations in NPHS1 or LAMB2 cause early-onset SRNS, whereas mutations in INF2 or TRPC6 cause late-onset SRNS. (C) Percentages of families with causative mutation detected (from B) are interconnected by lines between age groups and shown in different colors for each causative gene (lower panel for recessive genes, upper panel for dominant genes). NPHS1
Figure 3 Detection of the causative mutation in 502 families in an international cohort of 1617 families with SRNS in 21 SRNS-causing genes in relation to age of onset of proteinuria in clinically relevant age groups. The displayed 502 families represent the number of families with detected causative mutation and available data for age of onset of proteinuria , 26 years. (A) Percentage of families with causative mutation detected per gene per age group. Histograms indicate fraction (in percentage) of families with causative gene detected in n families per families examined (on top of histograms) per age group. (B) Percentages shown in A are represented by separate bars to highlight distribution across age groups as further delineated in C. Note that mutations in NPHS1 or LAMB2 cause early-onset SRNS, whereas mutations in INF2 or TRPC6 cause late-onset SRNS. (C) Percentages of families with causative mutation detected (from B) are interconnected by lines between age groups and shown in different colors for each causative gene (lower panel for recessive genes, upper panel for dominant genes). NPHS1CC-BY-NC-ND · From the PDF
Figure 4 Distribution for age of onset of NS in 35 individuals with homozygous mutations in PLCE1 . (A) Homozygous PLCE1 mutations are represented by 30 different alleles. The x-axis indicates the mutations sorted by median age of onset. The y-axis indicates the age of onset of SRNS. Symbols are colored red, green, or blue if the allele is truncating, splice, or missense, respectively. (B) Age of onset of SRNS with causative mutations detected in PLCE1 , grouped by type of mutation. The x-axis indicates the type of mutations (truncating mutations before amino acid (aa) residue 1000 (N-terminal), truncating mutations after aa residue 1000 (C-terminal), splice and
Figure 4 Distribution for age of onset of NS in 35 individuals with homozygous mutations in PLCE1 . (A) Homozygous PLCE1 mutations are represented by 30 different alleles. The x-axis indicates the mutations sorted by median age of onset. The y-axis indicates the age of onset of SRNS. Symbols are colored red, green, or blue if the allele is truncating, splice, or missense, respectively. (B) Age of onset of SRNS with causative mutations detected in PLCE1 , grouped by type of mutation. The x-axis indicates the type of mutations (truncating mutations before amino acid (aa) residue 1000 (N-terminal), truncating mutations after aa residue 1000 (C-terminal), splice andCC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

Items 601–651 of 651

Metadata

Authors
Sadowski, C. E., Lovric, S., Ashraf, S., Pabst, W. L., Gee, H. Y., Kohl, S., Engelmann, S., Vega-Warner, V., Fang, H., Halbritter, J., Somers, M. J., Tan, W., Shril, S., Fessi, I., Lifton, R. P., Bockenhauer, D., El-Desoky, S., Kari, J. A., Zenker, M., Kemper, M. J., Mueller, D., Fathy, H. M., Soliman, N. A., & Hildebrandt, F.
Affiliations
  • Boston Children's Hospital (US)
  • University of Michigan (US)
  • Howard Hughes Medical Institute (US)
  • King Abdul Aziz University Hospital (SA)
  • Otto-von-Guericke-Universität Magdeburg (DE)
  • University Medical Center Hamburg-Eppendorf (DE)
  • Stiftung Charité (DE)
  • Alexandria University (EG)
  • Cairo University (EG)
Corresponding author
  • Sadowski, Carolin E.
  • Lovric, Svjetlana
  • Ashraf, Shazia
  • Pabst, Werner L.
  • Gee, Heon Yung
  • Kohl, Stefan
  • Engelmann, Susanne
  • Fang, Humphrey
  • Halbritter, Jan
  • Somers, Michael J.
  • Tan, Weizhen
  • Shril, Shirlee
  • Fessi, Inès
  • Kemper, Markus J.
  • Hildebrandt, Friedhelm
Venue
Journal of the American Society of Nephrology
Published
2015-06
Volume
26
Issue
6
Pages
1279-1289
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2163605874
Cited by
651
References
41
Citations by year
2026: 45 · 2025: 40 · 2024: 45 · 2023: 63 · 2022: 69 · 2021: 61 · 2020: 55 · 2019: 55 · 2018: 64 · 2017: 62 · 2016: 50 · 2015: 40
FWCI
40.05
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Society of Nephrology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
  • Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Scholarship@Western (Western University) (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • Nephcure Foundation
  • Kidney Research UK (RP45/2008)
  • National Institutes of Health
  • Manton Center for Orphan Disease Research, Boston Children's Hospital
  • National Institute of Diabetes and Digestive and Kidney Diseases (RC4-DK076683, P30DK079310, R01DK076683)
Topics
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
  • Health Sciences › Medicine › Oncology › Renal and related cancers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
steroid-resistant nephrotic syndrome, NPHS2, WT1, PLCE1, coenzyme Q10 biosynthesis, age of onset, genotype-phenotype correlation, molecular genetic diagnosis, pediatric kidney disease, end-stage renal disease
MeSH terms
Adolescent, Adult, Child, Child, Preschool, Female, Genotype, Heterozygote, Humans, Infant, Male, Membrane Proteins, Middle Aged, Mutation, Nephrotic Syndrome, Pedigree, Phenotype, Retrospective Studies, Cohort Studies, Incidence, Genes, Wilms Tumor, Age of Onset, Risk Assessment, Genetic Predisposition to Disease, Intracellular Signaling Peptides and Proteins, Young Adult, Genetic Association Studies, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.